Ghost Tree Capital, LLC
- SEC CIK
- 0001595851
- Latest filing
- Nov 14, 2024
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 16, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 43
- −12 vs. Q3 2021
- Portfolio value
- $261.1M
- −$42.2M (−13.9%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CABACabaletta Bio, Inc. | COM | 135,000 | $512.0K | 0.2% | +35,000+35.0% | Added | History |
| PRDSPardes Biosciences, Inc. | COM | 50,000 | $819.0K | 0.3% | +50,000 | New | History |
| RETAReata Pharmaceuticals Inc | CL A | 55,000 | $1.45M | 0.6% | +55,000 | New | History |
| IMUXImmunic, Inc. | COM | 165,000 | $1.58M | 0.6% | −100,000−37.7% | Reduced | History |
| GBTGlobal Blood Therapeutics, Inc. | COM | 60,000 | $1.76M | 0.7% | +60,000 | New | History |
| GHRSGH Research PLC | ORDINARY SHARES | 100,000 | $2.33M | 0.9% | −300,000−75.0% | Reduced | History |
| LRMRLarimar Therapeutics, Inc. | COM | 225,000 | $2.43M | 0.9% | +25,000+12.5% | Added | History |
| DSGNDesign Therapeutics, Inc. | COM | 135,000 | $2.89M | 1.1% | +135,000 | New | History |
| CTICCti Biopharma Corp | COM | 1,200,000 | $2.98M | 1.1% | −400,000−25.0% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 100,000 | $3.12M | 1.2% | −690,000−87.3% | Reduced | History |
| KURAKura Oncology, Inc. | COM | 225,000 | $3.15M | 1.2% | −200,000−47.1% | Reduced | History |
| NMTR9 Meters Biopharma, Inc. | COM | 3,250,000 | $3.18M | 1.2% | +500,000+18.2% | Added | History |
| PYXSPyxis Oncology, Inc. | COMMON STOCK | 295,000 | $3.24M | 1.2% | +295,000 | New | History |
| CRNXCrinetics Pharmaceuticals, Inc. | COM | 118,344 | $3.36M | 1.3% | −31,656−21.1% | Reduced | History |
| Bellus Health Inc New07987C204 | COM NEW | 450,000 | $3.62M | 1.4% | +50,000+12.5% | Added | – |
| TARSTarsus Pharmaceuticals, Inc. | COM | 170,000 | $3.83M | 1.5% | 00.0% | Unchanged | History |
| VTGNVistagen Therapeutics, Inc. | COM NEW | 2,000,000 | $3.90M | 1.5% | 00.0% | Unchanged | History |
| STSASatsuma Pharmaceuticals, Inc. | COM | 904,225 | $4.07M | 1.6% | 00.0% | Unchanged | History |
| KZRKezar Life Sciences, Inc. | COM | 250,000 | $4.18M | 1.6% | +250,000 | New | History |
| CYPHCypherpunk Technologies Inc. | COM | 1,350,000 | $4.37M | 1.7% | −300,000−18.2% | Reduced | History |
| MRTXMirati Therapeutics, Inc. | COM | 30,000 | $4.40M | 1.7% | −30,000−50.0% | Reduced | History |
| RLMDRelmada Therapeutics, Inc. | COM | 200,000 | $4.51M | 1.7% | 00.0% | Unchanged | History |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 210,000 | $4.64M | 1.8% | +110,000+110.0% | Added | History |
| ACRSAclaris Therapeutics, Inc. | COM | 325,000 | $4.73M | 1.8% | +50,000+18.2% | Added | History |
| WHWKWhitehawk Therapeutics, Inc. | COM | 200,000 | $4.83M | 1.8% | +200,000 | New | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 750,000 | $5.04M | 1.9% | 00.0% | Unchanged | History |
| ALNYAlnylam Pharmaceuticals, Inc. | COM | 30,000 | $5.09M | 1.9% | +30,000 | New | History |
| SRRASierra Oncology, Inc. | COM NEW | 250,000 | $5.43M | 2.1% | +50,000+25.0% | Added | History |
| FOLDAmicus Therapeutics, Inc. | COM | 500,000 | $5.78M | 2.2% | +235,000+88.7% | Added | History |
| PCVXVaxcyte, Inc. | COM | 250,000 | $5.95M | 2.3% | +90,000+56.3% | Added | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 300,000 | $6.57M | 2.5% | −275,000−47.8% | Reduced | History |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 80,000 | $6.72M | 2.6% | +15,000+23.1% | Added | History |
| SRPTSarepta Therapeutics, Inc. | COM | 100,000 | $9.01M | 3.4% | +100,000 | New | History |
| ARVNArvinas, Inc. | COM | 110,000 | $9.04M | 3.5% | −40,000−26.7% | Reduced | History |
| RCKTRocket Pharmaceuticals, Inc. | COM | 425,000 | $9.28M | 3.6% | +75,000+21.4% | Added | History |
| VRDNViridian Therapeutics, Inc. | COM | 500,000 | $9.88M | 3.8% | +150,000+42.9% | Added | History |
| ISEEIVERIC bio, Inc. | COM | 625,000 | $10.4M | 4.0% | −100,000−13.8% | Reduced | History |
| MRUSMerus N.V. | COM | 350,000 | $11.1M | 4.3% | +275,000+366.7% | Added | History |
| RAPTRAPT Therapeutics, Inc. | COM | 350,000 | $12.9M | 4.9% | +100,000+40.0% | Added | History |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 350,000 | $13.5M | 5.2% | +95,000+37.3% | Added | History |
| COGTCogent Biosciences, Inc. | COM | 1,700,000 | $14.6M | 5.6% | +200,000+13.3% | Added | History |
| APLSApellis Pharmaceuticals, Inc. | COM | 325,000 | $15.4M | 5.9% | +125,000+62.5% | Added | History |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 190,000 | $25.6M | 9.8% | +70,000+58.3% | Added | History |
Options (3)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
Sold out since Q3 2021 (21)
Positions held at the end of Q3 2021 that are gone from this filing.
| Security | Class | Shares in Q3 2021 | Value in Q3 2021 | % of portfolio in Q3 2021 | History |
|---|---|---|---|---|---|
| IOVAIovance Biotherapeutics, Inc. | COM | 700,000 | $17.3M | 5.7% | History |
| ALLKAllakos Inc. | COM | 85,000 | $9.00M | 3.0% | History |
| ALDXAldeyra Therapeutics, Inc. | COM | 700,000 | $6.15M | 2.0% | History |
| AVIRAtea Pharmaceuticals, Inc. | COM | 150,000 | $5.26M | 1.7% | History |
| MLTXMoonLake Immunotherapeutics | COM CL A | 500,000 | $4.94M | 1.6% | History |
| PRAXPraxis Precision Medicines, Inc. | COM | 250,000 | $4.62M | 1.5% | History |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 100,000 | $4.16M | 1.4% | History |
| GYREGyre Therapeutics, Inc. | COM NEW | 1,000,000 | $4.11M | 1.4% | History |
| TCRRTCR2 Therapeutics Inc. | COM | 477,323 | $4.06M | 1.3% | History |
| ALLOAllogene Therapeutics, Inc. | COM | 150,000 | $3.85M | 1.3% | History |
| FATEFate Therapeutics Inc | COM | 50,000 | $2.96M | 1.0% | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 75,000 | $2.88M | 0.9% | History |
| MRNAModerna, Inc. | Stock | 5,300 | $2.04M | 0.7% | History |
| ALECAlector, Inc. | COM | 80,000 | $1.83M | 0.6% | History |
| FULCFulcrum Therapeutics, Inc. | COM | 50,000 | $1.41M | 0.5% | History |
| CMRXChimerix Inc | COM | 200,000 | $1.24M | 0.4% | History |
| OTICOtonomy, Inc. | COM | 450,000 | $864.0K | 0.3% | History |
| CASICASI Pharmaceuticals, Inc (DE) | COM | 650,000 | $774.0K | 0.3% | History |
| BNTXBioNTech SE | SPONSORED ADS | 2,000 | $546.0K | 0.2% | History |
| TBIOTelesis Bio Inc. | COM | 35,000 | $390.0K | 0.1% | History |
| PRVBProvention Bio, Inc. | COM | 50,000 | $320.0K | 0.1% | History |